GlassScriptPhysician profile
Harry R Keefe
NPI 1558326264
$6,557.14
in general payments reported to CMS, 2019-2025
50 companies · $786 in 2025
The $786 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $939 · 2020: $803 · 2021: $1,216 · 2022: $1,018 · 2023: $1,029 · 2024: $767 · 2025: $786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,581.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $757.87 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $711.75 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $622.41 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $467.76 | 2019-2025 | Otezla, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $356.43 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $350.91 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $332.37 | 2019-2024 | Eliquis, Camzyos |
| Lilly USA, LLC | $302.83 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $294.96 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $231.23 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $227.52 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $184.41 | 2019-2023 | Vaxneuvance, Vaxelis, M-M-R II |
| Astellas Pharma US INC | $168.83 | 2019-2025 | Veozah, Myrbetriq |
| Mylan Specialty L.P. | $159.80 | 2021-2023 | Yupelri |
| Eisai INC. | $95.91 | 2020-2021 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Keefe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.